An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.
Its weight-loss drug policy would fall to Trump's pick for health secretary, Robert F Kennedy Jr, and Mehmet Oz, Trump's ...
Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S.
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a serious complication.
Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...
Weight loss drugs are popular—but often expensive. Luckily, there are a few ways to lower the costs, which we explore in this article.
Weight-loss jabs, known as GLP-1 receptor agonists, work by reducing food cravings. The NPA has previously urged patients to ...